An Overview on COVID-19 and its Effect on Cardiovascular Diseases.

An Overview on COVID-19 and its Effect on Cardiovascular Diseases.
Endocr Metab Immune Disord Drug Targets. 2020 Dec 28;:
Authors: Hamadi A, Mahzari A, Hakami A, Hindawi S, Dobie G, Sayyed MI, Hamdi F, Nahari M, Jackson DE
Abstract
COVID-19 (Virus named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)) is a pandemic disease characterized with respiratory infection caused by coronavirus. It has worldwide after an outbreak began in Wuhan, China, in December 2019. SARS-CoV-2 has infected more than 15 million people globally. The disease severity and mortality increased in patients with heart-related comorbidities. Cardiovascular disease patients are more susceptible and infected with SARS-CoV-2. Early screening and managements these patients prevent or ameliorate adverse outcomes. Several treatments have been used to combat these effects as previously seen in MERS and SARS. This review will cover the association of cardiovascular diseases with COVID 19. It showed that cardiovascular diseases are common in patients with COVID- 19. Increased attention to highlight the gaps should be paid to the care of this unique group of patients.
PMID: 33371840 [PubMed - as supplied by publisher]

Source: Endocrine, Metabolic and Immune Disorders Drug Targets - December 28, 2020 Category: Endocrinology Authors: Hamadi A, Mahzari A, Hakami A, Hindawi S, Dobie G, Sayyed MI, Hamdi F, Nahari M, Jackson DE Tags: Endocr Metab Immune Disord Drug Targets Source Type: research